These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17953873)

  • 1. [Mammography screening--advantages and disadvantages].
    Olsen AH; Schwartz W; Vejborg IM
    Ugeskr Laeger; 2007 Sep; 169(36):2977-9. PubMed ID: 17953873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participation behaviour following a false positive test in the Copenhagen mammography screening programme.
    Andersen SB; Vejborg I; von Euler-Chelpin M
    Acta Oncol; 2008; 47(4):550-5. PubMed ID: 18465321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of Screening in Breast Cancer (COS-BC): development of a questionnaire.
    Brodersen J; Thorsen H
    Scand J Prim Health Care; 2008; 26(4):251-6. PubMed ID: 19034808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluating the benefits of mammographic breast cancer screening].
    Kullmann T; Misset JL
    Orv Hetil; 2010 Aug; 151(35):1409-14. PubMed ID: 20719714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medical information for nurses. Mass screening for breast cancer].
    Kluck HM
    Tijdschr Ziekenverpl; 1987 Nov; 41(22):719-22. PubMed ID: 3424350
    [No Abstract]   [Full Text] [Related]  

  • 7. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study.
    Olsen AH; Njor SH; Vejborg I; Schwartz W; Dalgaard P; Jensen MB; Tange UB; Blichert-Toft M; Rank F; Mouridsen H; Lynge E
    BMJ; 2005 Jan; 330(7485):220. PubMed ID: 15649904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pros and cons of early cancer detection in breast carcinoma].
    Callies R; Oberhoff C
    MMW Fortschr Med; 2005 Apr; 147(14):30-2. PubMed ID: 15887680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benefits and harms of mammography screening: understanding the trade-offs.
    Woloshin S; Schwartz LM
    JAMA; 2010 Jan; 303(2):164-5. PubMed ID: 20068211
    [No Abstract]   [Full Text] [Related]  

  • 10. Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark.
    Utzon-Frank N; Vejborg I; von Euler-Chelpin M; Lynge E
    Cancer Epidemiol; 2011 Oct; 35(5):393-8. PubMed ID: 21239242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The attendance of the first screening round (2002-2003) of the Hungarian organized breast cancer screening program and its effect on the number of diagnostic and screening mammography].
    Boncz I; Sebestyén A; Döbrossy L; Péntek Z; Kovács A; Csaba D; Budai A; Ember I
    Orv Hetil; 2005 Sep; 146(38):1963-70. PubMed ID: 16238249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mammography screening in the county of Copenhagen. Results of the first three screening rounds].
    Tange UB; Hirsch FR; Jensen MB; Olsen AH; Blichert-Toft M; Rank FE; Vejborg IM; Mouridsen H; Lynge E
    Ugeskr Laeger; 2002 Feb; 164(8):1048-52. PubMed ID: 11894707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The UK breast cancer screening programme: an expensive mistake.
    Rodgers A
    J Public Health Med; 1990; 12(3-4):197-204. PubMed ID: 2128025
    [No Abstract]   [Full Text] [Related]  

  • 14. [Psychological reactions connected to screening participation--illustrated by breast cancer screening].
    von Bülow B
    Ugeskr Laeger; 2002 Jan; 164(2):165-7. PubMed ID: 11831080
    [No Abstract]   [Full Text] [Related]  

  • 15. Mammography screening in the county of Fyn. November 1993-December 1999.
    Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
    APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammography screening for breast cancer: a view from 2 worlds.
    Murphy AM
    JAMA; 2010 Jan; 303(2):166-7. PubMed ID: 20068212
    [No Abstract]   [Full Text] [Related]  

  • 17. Organised mammographic screening--more benefits than harms.
    Hofvind S
    Tidsskr Nor Laegeforen; 2013 Mar; 133(6):619-20. PubMed ID: 23552154
    [No Abstract]   [Full Text] [Related]  

  • 18. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organised mammography screening reduces breast cancer mortality: a cohort study from Finland.
    Sarkeala T; Heinävaara S; Anttila A
    Int J Cancer; 2008 Feb; 122(3):614-9. PubMed ID: 17847022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographic screening for breast cancer: prospects for New Zealand.
    Skegg D; Paul C; Benson-Cooper D; Chetwynd J; Clarke A; Fitzgerald N; Gray A; St George I; Simpson A
    N Z Med J; 1988 Aug; 101(852):531-3. PubMed ID: 3045716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.